[The effect of the ultraphonophoesis of deresinated naphthalan in patients with a history of exudative pleurisy]. 1995

A B Insanov, and A V Musaev, and E A Gazvinova

Clinicoimmunological comparisons suggest the conclusion on positive effect of deresinated naphthalan phonophoresis when given early in the course of inpatient combined treatment of exudative pleurisy. The response was noted in the trend of clinical and immunological characteristics of T- and B-cell immunity.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D010996 Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. Effusion, Pleural,Effusions, Pleural,Pleural Effusions
D010998 Pleurisy INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN. Pleuritis,Pleurisies,Pleuritides
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

A B Insanov, and A V Musaev, and E A Gazvinova
January 1994, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
A B Insanov, and A V Musaev, and E A Gazvinova
January 2001, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
A B Insanov, and A V Musaev, and E A Gazvinova
January 2001, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
A B Insanov, and A V Musaev, and E A Gazvinova
January 1993, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
A B Insanov, and A V Musaev, and E A Gazvinova
February 1947, Revue medicale de la Suisse romande,
A B Insanov, and A V Musaev, and E A Gazvinova
December 2001, Klinichna khirurhiia,
A B Insanov, and A V Musaev, and E A Gazvinova
January 1992, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
A B Insanov, and A V Musaev, and E A Gazvinova
May 1969, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
A B Insanov, and A V Musaev, and E A Gazvinova
January 1947, Annales medicinae internae Fenniae,
A B Insanov, and A V Musaev, and E A Gazvinova
January 1994, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
Copied contents to your clipboard!